Weight loss may be slower in the first two weeks of your weight loss programme as the body adjusts
Because our cohort reflects heterogeneous real-world care without standardized assisted reproductive technology protocols, generalizability to women undergoing structured assisted reproductive technology treatment may be limited
While human relevance remains uncertain, patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 should not use either medication
A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
However, if you are high risk for heart disease, have had a heart event or the equivalent (stroke, stent), or do not require 15-20% weight loss, semaglutide / Wegovy may be a better choice
The proportion of patients achieving greater than 5%, 10%, and 15% weight loss was significantly higher in the tirzepatide group compared to the semaglutide group